Please login to the form below

Not currently logged in
Email:
Password:

AZ and Sutter Health enter cardiometabolic collaboration

Three-year partnership will design and pilot new treatments

AstraZeneca AZ headquarters London UK 

AstraZeneca has joined forces with not-for-profit organisation Sutter Health on a research and innovation collaboration on cardiometabolic healthcare.

The three-year partnership will work to design, prototype and pilot innovative approaches to the form of healthcare, which focuses on the treatment and management of diseases such as diabetes, hypertension and high cholesterol in addition to more common complications such as heart attack, blindness or death.

Greg Keenan, VP medical affairs and US medical officer at AZ, commented: “Diabetes, high blood pressure and poorly controlled cholesterol can have an enormous impact on a person's quality of life and the cost of healthcare.

“We believe that Sutter Health and AZ will bring together unique expertise and experiences to improve the lives of patients. 

“Through this innovative research collaboration, we hope to improve the future of cardiometabolic care and translate solutions into programmes that health systems nationwide could implement.”

Researchers will aim to help speed up diagnosis and improve the quality of life of patients by creating technologies and treatments through a better understanding of existing gaps in cardiometabolic care.

The collaboration will focus on three key areas; utilising key data from across the Sutter Health network into a electronic system and conduct novel analytical steps to identify gaps; personalising care by designing, developing and implementing new tools to help patients and providers work together; and supporting the continuous knowledge growth of researchers.

Article by
Kirstie Pickering

11th May 2015

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics